IgM/IgG

IgG

Antibodies are detected in the blood of people who are tested after infection; they show the body’s efforts to fight off a specific infection.

Korea FDA Approved (IgM/IgG, 2020.12.18)

US FDA-EUA Listed (IgG, 2020.09.03)

SGTi-flex COVID-19 IgM/IgG is a gold nanoparticle-based immunochromatographic test kit for qualitative determination of COVID-19’s IgM and IgG antibodies in human whole blood (finger prick or venous), serum or plasma.
The kits are accurate and easy to use and results can be observed with the naked eye within 10 minutes.
The test detects the presence of antibodies, which are specific proteins made in response to infections.
The antibodies detected by this test indicate that a person had an immune response to COVID-19, whether infection was asymptomatic.
Antibody test results are important in detecting infections with few or no symptoms
SGTi-flex COVID-19 IgM/IgG enables to help identify and isolate patients with no symptoms.

Jason Cho